Characteristics of pentazocine dependence in hospitalized patients after naloxone administration.
D000704:Analysis of Variance; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008297:Male; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D010423:Pentazocine / Q000008:administration & dosage / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D010919:Placebos; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders / Q000188:drug therapy*; D013997:Time Factors
D010919:Placebos; D009270:Naloxone; D010423:Pentazocine